Compare · head to head
Hansoh Pharmaceutical vs Sun Hung Kai Properties
Sun Hung Kai Properties ranks higher overall — 360 rank 98 vs 66.
Sun Hung Kai Properties leads on Value (61 vs 37), Growth (65 vs 50) and Safety (87 vs 69). Hansoh Pharmaceutical leads on Sentiment (50 vs 43). The two are close on Quality.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Hong Kong SAR China | Hong Kong SAR China |
| Sector | Health Care | Real Estate |
| Industry | Pharmaceuticals | Real Estate Management & Development |
| Size | Large | X-Large |
| ISIN | KYG549581067 | HK0016000132 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 66 | 98 |
| Value | 37 | 61 |
| Quality | 59 | 57 |
| Growth | 50 | 65 |
| Safety | 69 | 87 |
| Sentiment | 50 | 43 |
| Quality details | ||
| Profitability | 71 | 40 |
| Cash Truth | 48 | 75 |
Hansoh Pharmaceutical vs Takeda PharmaceuticalHansoh Pharmaceutical vs CSPC PharmaceuticalHansoh Pharmaceutical vs HUTCHMED (China)Hansoh Pharmaceutical vs Aprogen BiologicsAdd a third stock →
Full analyses: Hansoh Pharmaceutical · Sun Hung Kai Properties
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100